Estimate bleeding risk after NSTEMI.
The CRUSADE score was developed to stratify baseline risk of major bleeding in community-treated NSTEMI patients to support optimal treatment selection. Further research has also validated the score in patients with STEMI.
CRUSADE is an acronym from the full study title:Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines
Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, Wang TY, Gibler WB, Ohman EM, Roe MT, Pollack CV Jr.,Peterson ED, Alexander KP.
Circulation 2009 April 14, 119 (14): 1873-82
Abu-Assi E, Gracía-Acuña JM, Ferreira-González I, et al.
Circulation 2010 June 8, 121 (22): 2419-26
© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.
